← Back to directory

Mark I. van Berge Henegouwen

Researcher Next ID · RN-033765

Researcher · Medicine

Amsterdam University Medical Centers

Amsterdam, Netherlands

Accepting doctoral researchersFunding unknown
Works count
782
Citation count
36,544
H-index
84
i10-index
366

Research interests

Medicine
Esophageal Cancer Research and Treatment
Gastric Cancer Management and Outcomes
Esophageal and GI Pathology
Gastrointestinal Tumor Research and Treatment
Pancreatic and Hepatic Oncology Research

Publications

  • Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial

    Journal of Clinical Oncology · 2021 · 10.1200/jco.20.01540

  • Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

    The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00001-5

  • Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

    Clinical Cancer Research · 2021 · https://doi.org/10.1158/1078-0432.ccr-20-4443

  • Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

    Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03614

  • Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

    Journal of Clinical Oncology · 2021 · 10.1200/jco.20.03697

  • Global burden of oesophageal and gastric cancer by histology and subsite in 2018

    Gut · 2020 · https://doi.org/10.1136/gutjnl-2020-321600

  • Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment

    Diseases of the Esophagus · 2020 · 10.1093/dote/doaa039

  • Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

    Proceedings of the National Academy of Sciences · 2019 · 10.1073/pnas.1820459116

  • Reporting National Outcomes After Esophagectomy and Gastrectomy According to the Esophageal Complications Consensus Group (ECCG)

    Annals of Surgery · 2019 · 10.1097/sla.0000000000003210

  • Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30201-8

  • Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30132-3

  • Textbook outcome as a composite measure in oesophagogastric cancer surgery

    British journal of surgery · 2017 · 10.1002/bjs.10486

  • Minimally Invasive Versus Open Esophageal Resection

    Annals of Surgery · 2017 · 10.1097/sla.0000000000002171

  • Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy

    Annals of Surgery · 2017 · 10.1097/sla.0000000000002469

  • Defining Benchmarks for Transthoracic Esophagectomy

    Annals of Surgery · 2017 · 10.1097/sla.0000000000002445

  • A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands

    Annals of Surgery · 2017 · 10.1097/sla.0000000000002393

  • Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial

    World Journal of Surgery · 2015 · 10.1007/s00268-015-3100-y

  • Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

    The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00040-6

  • Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.51.2186

  • Remission of Barrett's Esophagus With Early Neoplasia 5 Years After Radiofrequency Ablation With Endoscopic Resection: A Netherlands Cohort Study

    Gastroenterology · 2013 · 10.1053/j.gastro.2013.03.046

  • Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial

    The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60516-9

  • Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

    New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1112088

  • Perioperative strategy in colonic surgery; LA paroscopy and/or FA st track multimodal management versus standard care (LAFA trial)

    BMC Surgery · 2006 · 10.1186/1471-2482-6-16

  • Delayed Gastric Emptying After Standard Pancreaticoduodenectomy Versus Pylorus-Preserving Pancreaticoduodenectomy: an Analysis of 200 Consecutive Patients

    Journal of the American College of Surgeons · 1997 · 10.1016/s1072-7515(01)00944-9

  • Incidence, Risk Factors, and Treatment of Pancreatic Leakage After Pancreaticoduodenectomy: Drainage versus Resection of the Pancreatic Remnant

    Journal of the American College of Surgeons · 1997 · 10.1016/s1072-7515(97)00007-0

Current projects

    No projects listed.